Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 2/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8585937 | 0.82 | ALDH1A1 (0.36) | GBA1ALDH1A1TDP1KDM4EMEN1 | |
| SCHEMBL6057032 | 0.81 | — | — | |
| SCHEMBL8149011 | 0.81 | HSD11B1 (0.47) | GBA1HSD11B1ALDH1A1TDP1KDM4E | |
| SCHEMBL4893194 | 0.81 | HSD11B1 (0.47) | GBA1HSD11B1ALDH1A1TDP1KDM4E | |
| SCHEMBL8353448 | 0.80 | GBA1 (0.46) | GBA1HSD11B1ALDH1A1KDM4EMEN1 | |
| SCHEMBL8584708 | 0.78 | ALDH1A1 (0.38) | ALDH1A1KDM4EMEN1KMT2ALMNA | |
| SCHEMBL1220049 | 0.77 | — | — | |
| SCHEMBL12454 | 0.77 | — | — | |
| SCHEMBL2074984 | 0.77 | — | — | |
| SCHEMBL9060463 | 0.76 | HSD11B1 (0.38) | GBA1HSD11B1ALDH1A1KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025030242-A1 | HYDROGEN SULFIDE TRAPPING COMPOUNDS, COMPOSITIONS COMPRISING SAME AND USES THEREOF | HYDRO-QUéBEC (CA) | 2025-02-13 | — | — | WO | disclosed |
| EP-3283600-B1 | METHOD OF REDUCING HYDROGEN SULFIDE LEVELS IN LIQUID OR GASEOUS STREAMS USING COMPOSITIONS COMPRISING TRIAZINES AND ANIONIC SURFACTANTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-09-25 | — | — | EP | disclosed |
| US-10155911-B2 | Method of reducing hydrogen sulfide levels in gaseous mixtures using triazines | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-12-18 | — | — | US | disclosed |
| US-20180044598-A1 | METHOD OF REDUCING HYDROGEN SULFIDE LEVELS IN GASEOUS MIXTURES USING TRIAZINES | DOW GLOBAL TECHNOLOGIES LLC | 2018-02-15 | — | — | US | disclosed |
| US-20100273833-A1 | 2-SULFINYL- AND 2-SULFONYL-SUBSTITUTED IMIDAZOLE DERIVATIVES AND THEIR USE AS CYTOKINE INHIBITORS | MERCKLE GMBH (DE) | 2010-10-28 | — | — | US | disclosed |
| EP-1853581-B1 | 2-SULFINYL- AND 2-SULFONYL-SUBSTITUTED IMIDAZOLE DERIVATIVES AND THEIR USE AS CYTOKINE INHIBITORS | MERCKLE GMBH (DE) | 2010-06-02 | — | — | EP | disclosed |
| US-20100069436-A1 | IMIDAZOLE COMPOUNDS HAVING AN ANTIINFLAMMATORY EFFECT | Merckle (DE) | 2010-03-18 | — | — | US | disclosed |
| EP-1894925-A1 | Imidazole compounds having an antiinflammatory effect | MERCKLE GMBH (DE) | 2008-03-05 | — | — | EP | disclosed |
| US-5744024-A | SCAVENGING USING MIXTURE OF HEXAHYDRO-1,3,5-TRIAZINE AND QUATERNARY AMMONIUM COMPOUND | NALCO/EXXON ENERGY CHEMICALS, L.P. (US) | 1998-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10155911-B2 | Method of reducing hydrogen sulfide levels in gaseous mixtures using triazines | TST, GSS, SCLY | GBA1 1763/4885HSD11B1 458/4885ALDH1A1 1207/4885 |
| US-20100069436-A1 | IMIDAZOLE COMPOUNDS HAVING AN ANTIINFLAMMATORY EFFECT | MIF, TNF, IL1B | GBA1 4303/4885HSD11B1 850/4885ALDH1A1 572/4885 |
| US-20100273833-A1 | 2-SULFINYL- AND 2-SULFONYL-SUBSTITUTED IMIDAZOLE DERIVATIVES AND THEIR USE AS CYTOKINE INHIBITORS | IL2, IL2RA, IL1B | GBA1 2783/4885HSD11B1 1421/4885ALDH1A1 658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.